News \ Non classé

Óskare Capital Webinar – The Endocannabinoid System

ÓSKARE CAPITAL's first Webinar focusses on the Endocannabinoid System (ECS) and the science behind the fund’s investment thesis.


You probably know that when people consume cannabis, the cannabinoids (>100) interact with this system in the human body and cause different effects in different parts of the body. However, you may not be aware that your own body produces cannabinoids and molecules that act on the ECS to regulate bodily functions.

Curious to understand why research scientists and doctors are so excited about the therapeutic potential of medical cannabis? This webinar explains what the ECS is, how our body reacts to substances and molecules that target the it and how targeting this system could address some of today’s unmet needs in medicine.

Thank you to the attendees for providing insightful questions in the Q&A section.

Presenters from ÓSKARE CAPITAL include:
John Rogers, MD, MPH (Chief Medical Officer)
Nicola Broughton, MBA, PhD, DipLaw (Managing Partner)
Zsolt Lenkei, MD, PHD (Operating Partner)

If you would like to hear more about the fund, please reach out to Oliver Lamb, Investment Manager, at